Waters Corp. WAT

NYS: WAT | ISIN: US9418481035   8/06/2026
363,34 USD (-0,55%)
(-0,55%)   8/06/2026

8 juni 2026 · Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis · Persbericht

3 juni 2026 · Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics · Persbericht

1 juni 2026 · Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics · Persbericht

1 juni 2026 · Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research · Persbericht

18 mei 2026 · Waters Corporation to Present at the Jefferies Global Healthcare Conference · Persbericht

5 mei 2026 · Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results · Persbericht

20 april 2026 · Waters Corporation Schedules First Quarter 2026 Earnings Conference Call · Persbericht

14 april 2026 · Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules · Persbericht

8 april 2026 · Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay · Persbericht

18 maart 2026 · Waters Prices Offering of Senior Notes · Persbericht

9 maart 2026 · Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed · Persbericht

23 februari 2026 · Waters Corporation to Present at the TD Cowen Health Care Conference · Persbericht

17 februari 2026 · Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage · Persbericht

9 februari 2026 · BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation · Persbericht

9 februari 2026 · Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses · Persbericht

9 februari 2026 · Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results · Persbericht

27 januari 2026 · BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business · Persbericht

27 januari 2026 · Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business · Persbericht

20 januari 2026 · Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call · Persbericht

23 december 2025 · Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 · Persbericht

Mijn selecties